drugset / Trial / NCT01602341
Efficacy and Safety of AN2728 Topical Ointment to Treat Adolescents With Atopic Dermatitis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine the safety and efficacy of AN2728 Topical Ointment, 2% and 0.5%, administered once a day (QD) or twice a day (BID), in the treatment of adolescents with atopic dermatitis (AD)
Timeline
- Start
- 2012-08
- Primary completion
- 2013-01
- Completion
- 2013-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Crisaborole | Small molecule | 0.5 % | Topical |
| Subject | Crisaborole | Small molecule | 2 % | Topical |